Phosphodiesterase inhibitors. Part 5: Hybrid PDE3/4 inhibitors as dual bronchorelaxant/anti-inflammatory agents for inhaled administration - Concepedia

Concepedia

Publication | Open Access

Phosphodiesterase inhibitors. Part 5: Hybrid PDE3/4 inhibitors as dual bronchorelaxant/anti-inflammatory agents for inhaled administration

DOI Full Paper Access

35

Citations

24

References

2012

Year

Koji Ochiai, Satoshi Takita, Akihiko Kojima, Tomohiko Eiraku, Kazuhiko Iwase, Tetsuya Kishi, Akira Ohinata, Yuichi Yageta, Tokutaro Yasue, David R. Adams,

Bioorganic & Medicinal Chemistry Letters

AsthmaAntifibrotic TherapyInflammatory Lung DiseaseLung InflammationMedicinePhosphodiesterase InhibitorsHybrid Pde3/4 InhibitorsPulmonary PharmacologyPharmacotherapyPulmonary MedicinePharmacologyPulmonary DiseaseDrug DiscoveryInhaled Administration

References

	Year	Citations

Page 1

Page 1